Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rayonier Advanced Materials Inc | Scott M. Sutton | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 1,500,000 | 1,500,000 | - | - | Performance Share Units | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 1,500,000 | 1,500,000 | - | - | Employee Stock Option (right to buy) | |
| HighPeak Energy Inc | Michael L. Hollis | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 550,000 | 1,978,312 | - | 0 | Common Stock, par value $0.0001 per share | |
| Atyr Pharma Inc | Jill M. Broadfoot | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 412,500 | 412,500 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Nancy E. Denyes | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 412,500 | 412,500 | - | - | Employee Stock Options (right to buy) | |
| Xenon Pharma Inc | Ian C. Mortimer | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 350,000 | 350,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 100,000 | 100,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 80,000 | 80,000 | - | - | Share Option (Right to Buy) | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 72,337 | 72,337 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 72,337 | 30,402,281 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.16 per share. | 09 Jan 2026 | 72,337 | 0 (0%) | 0% | 31.2 | 2,254,021 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 72,337 | 72,337 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.16 per share. | 09 Jan 2026 | 72,337 | 0 (0%) | 0% | 31.2 | 2,254,021 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 72,337 | 30,402,281 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 68,995 | 30,280,422 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 68,995 | 68,995 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 68,995 | 68,995 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 68,995 | 30,280,422 | - | - | Class B Common Stock | ||
| Xenon Pharma Inc | Ian C. Mortimer | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 65,000 | 65,000 | - | - | Restricted Share Units | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 09 Jan 2026 | 64,655 | 4,340 (0%) | 0% | 30.7 | 1,982,322 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 09 Jan 2026 | 64,655 | 4,340 (0%) | 0% | 30.7 | 1,982,322 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 55,556 | 1,112,458 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 55,556 | 1,112,458 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.22 per share. | 09 Jan 2026 | 55,556 | 0 | - | 19.2 | 1,067,864 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.22 per share. | 09 Jan 2026 | 55,556 | 0 | - | 19.2 | 1,067,864 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jan 2026 | 55,556 | 1,112,458 | - | 0 | Class V Voting Stock | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 55,556 | 55,556 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jan 2026 | 55,556 | 1,112,458 | - | 0 | Class V Voting Stock | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 55,556 | 55,556 | - | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 52,864 | 30,349,417 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 09 Jan 2026 | 52,864 | 0 (0%) | 0% | 31.3 | 1,655,700 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 52,864 | 52,864 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 52,864 | 52,864 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 09 Jan 2026 | 52,864 | 0 (0%) | 0% | 31.3 | 1,655,700 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 09 Jan 2026 | 52,864 | 30,349,417 | - | - | Class B Common Stock | ||
| HighPeak Energy Inc | Steven W. Tholen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 50,000 | 83,755 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | Rodney L. Woodard | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 50,000 | 204,138 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | Daniel M. Silver | Director, Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 50,000 | 301,652 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | William Ryan Hightower | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 50,000 | 372,668 | - | 0 | Common Stock, par value $0.0001 per share | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 47,223 | 1,243,385 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 09 Jan 2026 | 47,223 | 5,326,108 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.22 per share. | 09 Jan 2026 | 47,223 | 1,196,162 | - | 19.2 | 907,692 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jan 2026 | 47,223 | 5,326,108 | - | 0 | Class V Voting Stock | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 09 Jan 2026 | 46,777 | 6,640,023 | - | 5.4 | 250,257 | Common Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 09 Jan 2026 | 45,000 | 28,208,585 | - | 17.2 | 772,736 | Class A Commmon Stock |
| HighPeak Energy Inc | Keith E. Forbes | CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 25,000 | 25,000 | - | 0 | Common Stock, par value $0.0001 per share | |
| Agree Realty Corp | Richard Agree | Director, EXECUTIVE CHAIRMAN OF BOARD | Purchase of securities on an exchange or from another person at price $ 70.67 per share. | 09 Jan 2026 | 24,000 | 159,855 (0%) | 0% | 70.7 | 1,696,080 | Common Shares |
| Xenon Pharma Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| TeraWulf Inc | William Tanimoto | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 16,667 | 44,194 | - | - | Common stock, $0.001 par value per share | |
| TeraWulf Inc | William Tanimoto | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 16,667 | 16,666 | - | - | Restricted Stock Units | |
| Xenon Pharma Inc | Andrea DiFabio | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| OFG Bancorp | Jose Rafael Fernandez | Director, CEO; Chairman BOD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 13,481 | 198,155 (0%) | 0% | - | Common Stock | |
| OFG Bancorp | Jose Rafael Fernandez | Director, CEO; Chairman BOD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 13,481 | 44,685 | - | - | Restricted Units | |
| Medical Properties Trust Inc | Larry H. Portal | SVP, Senior Advisor to the CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.04 per share. | 09 Jan 2026 | 11,067 | 470,624 (0%) | 0% | 5.0 | 55,778 | Common stock, par value $0.001 |
| MainStreet Bancshares Inc | Richard Alexander Vari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 20.36 per share. | 09 Jan 2026 | 10,000 | 32,882 (0%) | 0% | 20.4 | 203,600 | Common Stock |
| Medical Properties Trust Inc | J. Kevin Hanna | Senior VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.04 per share. | 09 Jan 2026 | 9,274 | 434,294 (0%) | 0% | 5.0 | 46,741 | Common stock, par value $0.001 |
| Medical Properties Trust Inc | Rosa Handley Hooper | SVP of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.04 per share. | 09 Jan 2026 | 6,158 | 389,024 (0%) | 0% | 5.0 | 31,036 | Common stock, par value $0.001 |
| OFG Bancorp | Jose Rafael Fernandez | Director, CEO; Chairman BOD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.02 per share. | 09 Jan 2026 | 5,895 | 192,260 (0%) | 0% | 41.0 | 241,813 | Common Stock |
| TeraWulf Inc | William Tanimoto | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jan 2026 | 5,296 | 38,898 | - | - | Common stock, $0.001 par value per share | |
| Phillips 66 | Vanessa L. Allen Sutherland | EVP, GC and Secretary | Sale of securities on an exchange or to another person at price $ 145.00 per share. | 09 Jan 2026 | 4,394 | 30,193 (0%) | 0% | 145 | 637,130 | Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 09 Jan 2026 | 4,340 | 0 (0%) | 0% | 31.1 | 134,757 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 09 Jan 2026 | 4,340 | 0 (0%) | 0% | 31.1 | 134,757 | Class A Common Stock |
| Dycom Ind Inc | Eitan Gertel | Director | Sale of securities on an exchange or to another person at price $ 345.62 per share. | 09 Jan 2026 | 3,645 | 15,997 (0%) | 0% | 345.6 | 1,259,785 | Common Stock |
| Rollins | Thomas D. Tesh | Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 60.06 per share. | 09 Jan 2026 | 2,396 | 29,231 (0%) | 0% | 60.1 | 143,904 | Common Stock |
| Lakeland Ind Inc | An Hui | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 8.97 per share. | 09 Jan 2026 | 2,000 | 72,850 (0%) | 0% | 9.0 | 17,940 | Common Stock, par value $.01 per share |
| Lightbridge Corp | Jesse L. Funches | Director | Sale of securities on an exchange or to another person at price $ 16.96 per share. | 09 Jan 2026 | 1,449 | 74,022 (2%) | 0% | 17.0 | 24,572 | Common Stock |
| Alliant Energy | Christie Raymond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 1,172 | 7,486 | - | - | Deferred Common Stock Units | |
| Edwards Lifesciences | Daniel J. Lippis | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 09 Jan 2026 | 1,019 | 23,020 (0%) | 0% | 59.3 | 60,383 | Common Stock |
| Edwards Lifesciences | Daniel J. Lippis | CVP, TAVR | Sale of securities on an exchange or to another person at price $ 85.70 per share. | 09 Jan 2026 | 1,019 | 22,001 (0%) | 0% | 85.7 | 87,332 | Common Stock |
| Edwards Lifesciences | Daniel J. Lippis | CVP, TAVR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 1,019 | 4,076 | - | - | Employee Stock Option (Right to Acquire) | |
| Lakeland Ind Inc | James Calven Swinea | Interim CFO | Purchase of securities on an exchange or from another person at price $ 8.71 per share. | 09 Jan 2026 | 1,000 | 7,305 (0%) | 0% | 8.7 | 8,710 | Common Stock, par value $.01 per share |
| Alliant Energy | Michael Dennis Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 984 | 24,700 | - | - | Deferred Common Stock Units | |
| FTAI infra Inc | James L. Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 984 | 8,400 | - | 0 | Common Stock, par value $0.01 per share | |
| Alliant Energy | Nancy Joy Falotico | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 874 | 18,711 | - | - | Deferred Common Stock Units | |
| Alliant Energy | Roger K. Newport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 865 | 30,447 | - | - | Deferred Common Stock Units | |
| Alliant Energy | Ignacio A. Cortina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 749 | 9,489 | - | - | Deferred Common Stock Units | |
| Alliant Energy | Stephanie L. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 615 | 16,581 | - | - | Deferred Common Stock Units | |
| Alliant Energy | Patrick E. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 576 | 44,665 | - | - | Deferred Common Stock Units | |
| Brady Corp (Class A) | Patrick W. Allender | Director | Grant, award, or other acquisition of securities at price $ 82.21 per share. | 09 Jan 2026 | 296 | 100,510 (0%) | 0% | 82.2 | 24,334 | Class A Common Stock |
| Lennox International | Sivasankaran Somasundaram | Director | Grant, award, or other acquisition of securities at price $ 530.22 per share. | 09 Jan 2026 | 49 | 716 (0%) | 0% | 530.2 | 25,981 | Common Stock, Par Value $0.01 Per Share |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.